Mohnish Pabrai and the Cloning Strategy

Mohnish Pabrai is an investment cloner who systematically extracts the best ideas from 13-F filings and shareholder letters of legendary investors, then deploys capital into those same positions before they reach mainstream attention. Rather than pretend to original insight, Pabrai explicitly copies the homework of value investors he admires—chiefly Berkshire Hathaway’s portfolio, certain hedge fund public companies, and distressed-security specialists. The result is a philosophy that demands intellectual humility, ruthless focus, and the discipline to hold highly concentrated positions for years.

The Dhandho Philosophy

Pabrai borrows the term “Dhandho” from Gujarati and Indian business culture—it means “business” in the language, but Pabrai uses it to label a specific investing mindset: focus on opportunities with high odds of success and limited downside. Rather than chase novel insights or chase markets, he asks a simpler question: What have proven investors already figured out that I can understand?

This is a radical act of intellectual modesty in an industry built on ego. Most fund managers advertise proprietary research, unique data feeds, and superior predictive powers. Pabrai does the opposite. He argues that the best research has already been done by investors with ten or twenty times his capital and decades of experience. The 13-F filing—a public disclosure that mutual funds and hedge funds must file quarterly to reveal their stock positions—is a legal window into that research. Pabrai reads it like an apprentice reading a master craftsman’s blueprints.

The insight is that there is a gap between the time a 13-F is filed (and becomes public) and the time other investors analyse and act on it. That gap is Pabrai’s edge: the ability to read a 13-F, understand which position is the most promising, and deploy capital quickly, before consensus fragments and the position has moved.

The Cloning Process

Pabrai’s actual method is disciplined:

1. Source identification. Identify investors with a long track record of concentrated, long-term positions and transparent communication. These include Berkshire Hathaway (disclosed via annual letters and SEC filings), particular hedge funds, and publicly traded investment companies.

2. 13-F parsing. Review the quarterly 13-F filing, noting which positions are new, which have grown or shrunk, and which remain stable over time.

3. Conviction filtering. Focus only on the most significant positions—the ones that represent the largest percentage of the investor’s portfolio. A position accounting for 10+ per cent of portfolio assets likely reflects deep conviction.

4. Due diligence. Rather than clone blindly, Pabrai conducts his own accounting review of the company: balance sheet health, earnings quality, competitive position, and valuation relative to historical multiples.

5. Deployment. If due diligence confirms the position is sound, Pabrai deploys capital, sometimes matching the superinvestor’s position size as a percentage of his own portfolio, sometimes allocating more if he has higher conviction or less if he wants to limit concentration risk.

The key advantage is speed and clarity: he is not trying to outthink the original investor; he is validating their work and executing faster than the broader market.

Concentration and Patience

A critical element of Pabrai’s strategy is concentration. Rather than own 50 or 100 stocks, his funds typically hold 8–15 core positions, each representing meaningful percentage of assets. This is uncomfortable for most investors—a single bad pick can derail annual returns—but it is a deliberate choice.

Pabrai argues that if you have done proper due diligence and copied a proven investor’s homework, you should have conviction to hold a large position. Owning dozens of mediocre stocks dilutes that conviction and guarantees you will underperform. Instead, he builds a portfolio of his highest-conviction ideas and holds them for years.

This also requires patience. A cloned position might take 18–36 months to appreciate meaningfully. During that period, the market may favour other stocks or sectors. Pabrai accepts this opportunity cost as the price of conviction.

Notable Clones and Outcomes

Several of Pabrai’s public positions illustrate the approach. In the early 2000s, he identified that Berkshire Hathaway was accumulating positions in financial services and insurance-related businesses during a bear market, when valuations were depressed. Pabrai cloned several of those positions, buying beaten-down financial stocks before the recovery. The bull market of 2003–2007 rewarded that conviction.

During the 2008–2009 financial crisis, when credit markets froze and securitised assets became worthless, Pabrai again followed superinvestors into cheap, out-of-favour positions in financial institutions and distressed real estate. By concentrating capital where he had high confidence in a recovery—a conviction borrowed from his models’ positioning—he captured substantial gains in the 2009–2012 rebound.

More recently, Pabrai has discussed cloning positions from other concentrated investors, including those who hold significant stakes in emerging-market or technology companies. The method remains the same: read the filing, validate the thesis, deploy capital, and wait.

The Critique: Over-Reliance and Crowding

Pabrai’s cloning philosophy faces a pointed critique: if everyone reads the same 13-F filing and reaches the same conclusions, does the edge disappear? If multiple hedge funds clone the same superinvestor’s position, does that not create a crowded trade that amplifies both upside and downside?

Pabrai acknowledges this risk but argues that it is manageable. First, most investors are too busy or too proud to read 13-Fs carefully and act quickly. Second, Pabrai’s validation step—his own due diligence—often leads him to clone only a subset of the positions he reads, so his portfolio diverges from others doing the same exercise. Third, the time lag between filing and public awareness usually provides a window; Pabrai can move capital and accumulate a position before the crowd.

Still, there have been periods when Pabrai’s concentrated positions underperformed broadly. If a cloned idea turns out to have a flaw Pabrai missed, the concentrated portfolio amplifies the loss. Over Pabrai’s career, this has occasionally happened, and investors have cycled in and out accordingly.

The Intellectual Honesty Factor

What distinguishes Pabrai from many competitors is his explicit refusal to claim genius. In annual letters and interviews, he openly credits his returns to the homework of others, not to superior predictive ability or exotic data. This honesty has earned him respect, particularly among value investors who prize intellectual integrity.

His books and lectures encourage investors to study the letters of Berkshire Hathaway, value investors like Chanticleer Capital and Pabrai Investment Funds, and distressed-sector specialists. He is, in effect, teaching others his cloning method, which paradoxically strengthens the competitive pressure to execute better and move faster.

For investors who lack the time or expertise to conduct deep accounting research, or who lack confidence in their ability to identify original opportunities, cloning from proven superinvestors offers a transparent alternative: copy the best homework and wait. It is not glamorous, but it has produced solid, above-market returns over decades.

See also